Earnings Reports: Positive earnings reports typically drive the stock price up, while negative reports can cause it to fall.

Economic Conditions: Overall economic health, including GDP growth and inflation, can impact investor sentiment and the stock's value.

Industry Trends: The performance of the broader pharmaceutical industry influences GMAT3.SA's stock price, as investors assess sector-wide prospects.

Company News: Announcements about new products, partnerships, acquisitions, or regulatory approvals significantly affect the stock's valuation.

Market Sentiment: General investor optimism or pessimism in the market can create buying or selling pressure on GMAT3.SA, regardless of fundamentals.

Interest Rates: Changes in interest rates can impact borrowing costs for the company and influence investment decisions, thereby affecting the stock price.

Global Events: International events, such as geopolitical tensions or global health crises, can create uncertainty and affect investor behavior toward GMAT3.SA.